<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37096581</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Phenotype Risk Score but Not Genetic Risk Score Aids in Identifying Individuals With Systemic Lupus Erythematosus in the Electronic Health Record.</ArticleTitle><Pagination><StartPage>1532</StartPage><EndPage>1541</EndPage><MedlinePgn>1532-1541</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.42544</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Systemic lupus erythematosus (SLE) poses diagnostic challenges. We undertook this study to evaluate the utility of a phenotype risk score (PheRS) and a genetic risk score (GRS) to identify SLE individuals in a real-world setting.</AbstractText><AbstractText Label="METHODS">Using a de-identified electronic health record (EHR) database with an associated DNA biobank, we identified 789 SLE cases and 2,261 controls with available MEGA<sup>EX</sup> genotyping. A PheRS for SLE was developed using billing codes that captured American College of Rheumatology SLE criteria. We developed a GRS with 58 SLE risk single-nucleotide polymorphisms (SNPs).</AbstractText><AbstractText Label="RESULTS">SLE cases had a significantly higher PheRS (mean &#xb1; SD 7.7 &#xb1;&#x2009;8.0 versus 0.8 &#xb1;&#x2009;2.0 in controls; P &lt;&#x2009;0.001) and GRS (mean &#xb1; SD 12.2 &#xb1;&#x2009;2.3 versus 11.0 &#xb1;&#x2009;2.0 in controls; P &lt;&#x2009;0.001). Black individuals with SLE had a higher PheRS compared to White individuals (mean &#xb1; SD 10.0 &#xb1;&#x2009;10.1 versus 7.1 &#xb1;&#x2009;7.2, respectively; P =&#x2009;0.002) but a lower GRS (mean &#xb1; SD 9.0 &#xb1;&#x2009;1.4 versus 12.3 &#xb1;&#x2009;1.7, respectively; P &lt;&#x2009;0.001). Models predicting SLE that used only the PheRS had an area under the curve (AUC) of 0.87. Adding the GRS to the PheRS resulted in a minimal difference with an AUC of 0.89. On chart review, controls with the highest PheRS and GRS had undiagnosed SLE.</AbstractText><AbstractText Label="CONCLUSION">We developed a SLE PheRS to identify established and undiagnosed SLE individuals. A SLE GRS using known risk SNPs did not add value beyond the PheRS and was of limited utility in Black individuals with SLE. More work is needed to understand the genetic risks of SLE in diverse populations.</AbstractText><CopyrightInformation>&#xa9; 2023 American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barnado</LastName><ForeName>April</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9573-4335</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Immunology, Department of Medicine, and Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wheless</LastName><ForeName>Lee</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Epidemiology, Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camai</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katta</LastName><ForeName>Anish</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology &amp; Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>All of Us Research Program, NIH, Bethesda, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawalha</LastName><ForeName>Amr H</ForeName><Initials>AH</Initials><Identifier Source="ORCID">0000-0002-3884-962X</Identifier><AffiliationInfo><Affiliation>Departments of Pediatrics, Medicine, and Immunology, and Lupus Center of Excellence, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 AR072757</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>IK2 CX002452</GrantID><Acronym>CX</Acronym><Agency>CSRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI097134</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR080629</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095223" MajorTopicYN="N">White</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest</b>: none</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>25</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37096581</ArticleId><ArticleId IdType="mid">NIHMS1924986</ArticleId><ArticleId IdType="pmc">PMC10501317</ArticleId><ArticleId IdType="doi">10.1002/art.42544</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Durcan L, Petri M. Why targeted therapies are necessary for systemic lupus erythematosus. Lupus 2016;25:1070&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4978144</ArticleId><ArticleId IdType="pubmed">27497251</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramanik B Diagnosis of systemic lupus erythematosus in an unusual presentation: what a primary care physician should know. Curr Rheumatol Rev 2014;10:81&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25599686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nightingale AL, Davidson JE, Molta CT, Kan HJ, McHugh NJ. Presentation of SLE in UK primary care using the Clinical Practice Research Datalink. Lupus Sci Med 2017;4:e000172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5307373</ArticleId><ArticleId IdType="pubmed">28243454</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees F, Doherty M, Lanyon P, Davenport G, Riley RD, Zhang W, et al. Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model. Arthritis Care Res (Hoboken) 2017;69:833&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27588834</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen NJ, Karp DR. Finding lupus in the ANA haystack. Lupus Sci Med 2020;7:e000384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7008709</ArticleId><ArticleId IdType="pubmed">32095251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastiani GD, Prevete I, Iuliano A, Piga M, Iannone F, Coladonato L, et al. Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset. Lupus 2018;27:1479&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">29779436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastarache L, Hughey JJ, Hebbring S, Marlo J, Zhao W, Ho WT, et al. Phenotype risk scores identify patients with unrecognized Mendelian disease patterns. Science 2018;359:1233&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5959723</ArticleId><ArticleId IdType="pubmed">29590070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong X, Yin Z, Jia G, Zhou D, Wei Q, Faucon A, et al. Electronic health record phenotypes associated with genetically regulated expression of CFTR and application to cystic fibrosis. Genet Med 2020;22:1191&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781195</ArticleId><ArticleId IdType="pubmed">32296164</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastarache L Using Phecodes for Research with the Electronic Health Record: From PheWAS to PheRS. Annu Rev Biomed Data Sci 2021;4:1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307256</ArticleId><ArticleId IdType="pubmed">34465180</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb R, Kelly JA, Somers EC, Hughes T, Kaufman KM, Sanchez E, et al. Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients. Ann Rheum Dis 2011;70:151&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3034281</ArticleId><ArticleId IdType="pubmed">20881011</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KE, Chung SA, Graham RR, Ortmann WA, Lee AT, Langefeld CD, et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet 2011;7:e1001311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3040652</ArticleId><ArticleId IdType="pubmed">21379322</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo YB, Lim J, Tsao BP, Nath SK, Kim K, Bae SC. Genetic variants in systemic lupus erythematosus susceptibility loci, XKR6 and GLT1D1 are associated with childhood-onset SLE in a Korean cohort. Sci Rep 2018;8:9962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6028392</ArticleId><ArticleId IdType="pubmed">29967481</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun 2017;8:16021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco MA, Balzer L, Taylor KE, Trupin L, Nititham J, Seldin MF, et al. Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation. Genes Immun 2016;17:358&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5008986</ArticleId><ArticleId IdType="pubmed">27467283</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Wang YF, Liu L, Bielowka A, Ahmed R, Zhang H, et al. Genome-wide assessment of genetic risk for systemic lupus erythematosus and disease severity. Hum Mol Genet 2020;29:1745&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322569</ArticleId><ArticleId IdType="pubmed">32077931</ArticleId></ArticleIdList></Reference><Reference><Citation>Webber D, Cao J, Dominguez D, Gladman DD, Levy DM, Ng L, et al. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE. Rheumatology (Oxford) 2020;59:90&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31236574</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid S, Alexsson A, Frodlund M, Morris D, Sandling JK, Bolin K, et al. High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus. Ann Rheum Dis 2020;79:363&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7034364</ArticleId><ArticleId IdType="pubmed">31826855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes T, Adler A, Merrill JT, Kelly JA, Kaufman KM, Williams A, et al. Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus. Ann Rheum Dis 2012;71:694&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3324666</ArticleId><ArticleId IdType="pubmed">22110124</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez D, Kamphuis S, Beyene J, Wither J, Harley JB, Blanco I, et al. Relationship Between Genetic Risk and Age of Diagnosis in Systemic Lupus Erythematosus. J Rheumatol 2021;48:852&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">33060314</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden DM, Pulley JM, Basford MA, Bernard GR, Clayton EW, Balser JR, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther 2008;84:362&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763939</ArticleId><ArticleId IdType="pubmed">18500243</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley ITW, Sawalha AH. Systemic lupus erythematosus as a genetic disease. Clin Immunol 2022;236:108953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9167620</ArticleId><ArticleId IdType="pubmed">35149194</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, Casey C, Carroll RJ, Wheless L, Denny JC, Crofford LJ. Developing Electronic Health Record Algorithms That Accurately Identify Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2017;69:687&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5219863</ArticleId><ArticleId IdType="pubmed">27390187</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, Carroll RJ, Casey C, Wheless L, Denny JC, Crofford LJ. Phenome-Wide Association Studies Uncover a Novel Association of Increased Atrial Fibrillation in Male Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 2018;70:1630&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6109620</ArticleId><ArticleId IdType="pubmed">29481723</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, Carroll RJ, Casey C, Wheless L, Denny JC, Crofford LJ. Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus. Arthritis Res Ther 2018;20:69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5894248</ArticleId><ArticleId IdType="pubmed">29636090</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, Carroll RJ, Casey C, Wheless L, Denny JC, Crofford LJ. Phenome-wide association study identifies dsDNA as a driver of major organ involvement in systemic lupus erythematosus. Lupus 2019;28:66&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389392</ArticleId><ArticleId IdType="pubmed">30477398</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong WW, Boone JB, Wheless L, Chung CP, Crofford LJ, Barnado A. Real-world electronic health record identifies antimalarial underprescribing in patients with lupus nephritis. Lupus 2019;28:977&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6609095</ArticleId><ArticleId IdType="pubmed">31189414</ArticleId></ArticleIdList></Reference><Reference><Citation>Boone JB, Wheless L, Camai A, Tanner SB, Barnado A. Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure. Lupus 2021;30:403&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933066</ArticleId><ArticleId IdType="pubmed">33307984</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandelman JS, Khan OA, Shuey MM, Neal JE, McNeer E, Dickson A, et al. Increased Incidence of Resistant Hypertension in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study. Arthritis Care Res (Hoboken) 2020;72:534&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6745299</ArticleId><ArticleId IdType="pubmed">30875459</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982. revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 82;25:1271&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris DL, Sheng Y, Zhang Y, Wang YF, Zhu Z, Tombleson P, et al. Genome-wide association meta-analysis in Chinese and European individuals identifies ten new loci associated with systemic lupus erythematosus. Nat Genet 2016;48:940&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4966635</ArticleId><ArticleId IdType="pubmed">27399966</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumitrescu L, Ritchie MD, Brown-Gentry K, Pulley JM, Basford M, Denny JC, et al. Assessing the accuracy of observer-reported ancestry in a biorepository linked to electronic medical records. Genet Med 2010;12:648&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2952033</ArticleId><ArticleId IdType="pubmed">20733501</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum 2019;49:S14&#x2013;S7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31779843</ArticleId></ArticleIdList></Reference><Reference><Citation>Aref L, Bastarache L, Hughey JJ. The phers R package: using phenotype risk scores based on electronic health records to study Mendelian disease and rare genetic variants. Bioinformatics 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9620826</ArticleId><ArticleId IdType="pubmed">36083022</ArticleId></ArticleIdList></Reference><Reference><Citation>Costenbader KH, Desai A, Alarcon GS, Hiraki LT, Shaykevich T, Brookhart MA, et al. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum 2011;63:1681&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3106117</ArticleId><ArticleId IdType="pubmed">21445962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SS, Bayakly AR, Helmick CG, Gordon C, Easley KA, Drenkard C. The incidence and prevalence of systemic lupus erythematosus, 2002&#x2013;2004: The Georgia Lupus Registry. Arthritis Rheumatol. 2014;66:357&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4617771</ArticleId><ArticleId IdType="pubmed">24504808</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan M, Harwood R, Sutton S, D&#x2019;Cruz D, Howard P, Wincup C, et al. Medically explained symptoms: a mixed methods study of diagnostic, symptom and support experiences of patients with lupus and related systemic autoimmune diseases. Rheumatol Adv Pract 2020;4:rkaa006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197794</ArticleId><ArticleId IdType="pubmed">32373774</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamichou C, Genitsaridi I, Nikolopoulos D, Nikoloudaki M, Repa A, Bortoluzzi A, et al. Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Ann Rheum Dis 2021;80:758&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142436</ArticleId><ArticleId IdType="pubmed">33568388</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker SC, Creech CB, Domenico HJ, French B, Byrne DW, Wheeler AP. A Real-time Risk-Prediction Model for Pediatric Venous Thromboembolic Events. Pediatrics 2021;147:e2020042325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168609</ArticleId><ArticleId IdType="pubmed">34011634</ArticleId></ArticleIdList></Reference><Reference><Citation>Freundlich RE, Li G, Domenico HJ, Moore RP, Pandharipande PP, Byrne DW. A Predictive Model of Reintubation After Cardiac Surgery Using the Electronic Health Record. Ann Thorac Surg 2022;113:2027&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792101</ArticleId><ArticleId IdType="pubmed">34329600</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, McGregor TL, Jones DP, Bridges BC, Fleming GM, Shirey-Rice J, et al. Electronic health record-based predictive models for acute kidney injury screening in pediatric inpatients. Pediatr Res 2017;82:465&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570660</ArticleId><ArticleId IdType="pubmed">28486440</ArticleId></ArticleIdList></Reference><Reference><Citation>Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992;35:311&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1536669</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunner HI, Gladman DD, Ibanez D, Urowitz MD, Silverman ED. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008;58:556&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">18240232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 2009;61:13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875186</ArticleId><ArticleId IdType="pubmed">19116979</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker LB, Uribe AG, Fernandez M, Vila LM, McGwin G, Apte M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008;17:314&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2818044</ArticleId><ArticleId IdType="pubmed">18413413</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers EC, Marder W, Cagnoli P, Lewis EE, DeGuire P, Gordon C, et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. Arthritis Rheumatol 2014;66:369&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4198147</ArticleId><ArticleId IdType="pubmed">24504809</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Ahlford A, Jarvinen TM, Nordmark G, Eloranta ML, Gunnarsson I, et al. Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J Hum Genet 2013;21:994&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3746253</ArticleId><ArticleId IdType="pubmed">23249952</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Raychaudhuri S, Karlson EW, Speyer C, Malspeis S, Guan H, et al. Interactions Between Genome-Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus. Arthritis Rheumatol 2020;72:1863&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722161</ArticleId><ArticleId IdType="pubmed">32969204</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009;41:1234&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19838193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Narvaez EA, Fraser PA, Palmer JR, Cupples LA, Reich D, Wang YA, et al. MHC region and risk of systemic lupus erythematosus in African American women. Hum Genet 2011;130:807&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3215804</ArticleId><ArticleId IdType="pubmed">21695597</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>